Ayrika Capsule 75 mg (Pregabalin)

Adult dose

This medication should be taken orally, divided into two doses per day, regardless of food intake. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose of 150 mg per day, can increase to 300 mg per day after 3 to 7 days, and can be adjusted to a maximum of 600 mg per day after 7-day intervals if necessary. - Central neuropathic pain: Starting dose of 150 mg per day, can increase to 300 mg per day after 1 week.

Child dose

There is insufficient safety and efficacy data for children under 12 years of age and adolescents aged 12 to 17 years, so administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so if depressive symptoms or mood changes occur during use, consult a healthcare professional immediately. Patients with hypersensitivity to any of the components should not take this medication. Diabetic patients may need to adjust their blood sugar control medications due to weight gain, so caution is advised. If symptoms of allergic reactions such as angioedema occur, stop taking the medication immediately and inform healthcare personnel. Elderly patients may experience dizziness, drowsiness, or loss of consciousness, thus they should exercise special caution, especially during the initial stages of use. If visual disturbances or changes in vision occur, discontinuing this medication may improve the symptoms. Before using this medication as monotherapy, consult with healthcare personnel about discontinuing any previously taken antiepileptic drugs. When stopping this medication, withdrawal symptoms such as insomnia, anxiety, and headaches may occur, so it should be tapered off gradually according to medical advice. Patients with a history of drug abuse may have a higher risk of misuse with this medication and should use it cautiously. Patients with reduced kidney function may require dosage adjustments. Patients with heart disease should be careful due to the risk of congestive heart failure. When taken with opioid analgesics, there is an increased risk of central nervous system depression. Patients with respiratory function impairment or the elderly should discuss the risk of severe respiratory depression with healthcare personnel. Women of childbearing age should use effective contraception prior to taking this medication in the early stages of pregnancy as it may pose a risk of fetal malformation. It is advisable to avoid activities that require alertness, such as driving or operating machinery, until dizziness or drowsiness has resolved. If severe skin reactions occur, stop taking the medication immediately and inform healthcare personnel. In case of overdose, symptoms such as confusion, drowsiness, and depression may occur, so immediate medical treatment is necessary. Keep out of reach of children, and do not transfer to other containers for safety.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of the skin or eyes), extreme drowsiness, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

• Dizziness
• drowsiness
• confusion
• impaired spatial orientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to prevent air or moisture ingress. It should be kept in a cool place between 15 degrees and 30 degrees.

Appearance

A hard capsule with a reddish-brown upper part and a white lower part filled with a white or slightly yellow powder

Package unit

30 capsules/bottle, 100 capsules/bottle